Molecular characterization of the HLA-Cw*0409N allele.

[1]  R. Blasczyk,et al.  Non-expression of HLA-B*5111N is caused by an insertion into the cytosine island at exon 4 creating a frameshift stop codon. , 2001, Tissue antigens.

[2]  J. Tiercy,et al.  Sequence of a new class I null allele within the HLA-B44 specificity. , 2000, Tissue antigens.

[3]  R. Powers,et al.  Structural Relatedness of Distinct Determinants Recognized by Monoclonal Antibody TP25.99 on β2-Microglobulin-Associated and β2-Microglobulin-Free HLA Class I Heavy Chains1 , 2000, The Journal of Immunology.

[4]  A. Toubert,et al.  A novel HLA-B null allele (B*4022N) generated by a nonsense codon in the alpha1 domain. , 2000, Tissue antigens.

[5]  G. Sirchia,et al.  A nucleotide deletion in exon 4 is responsible for an HLA-A null allele (A*0105N). , 1999, Tissue antigens.

[6]  J. Cazenave,et al.  A null HLA-A*68 allele in a bone marrow donor. , 1999, Tissue antigens.

[7]  A. Little,et al.  Aberrant splicing of intron 1 creates a novel null HLA-B*1501 allele. , 1999, Tissue antigens.

[8]  D. Middleton,et al.  Detection of HLA-A*24 null alleles by DNA typing methods. , 1998, Tissue antigens.

[9]  J. Cazenave,et al.  A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-A*01 allele. , 1997, Tissue antigens.

[10]  K. Tokunaga,et al.  An HLA-B null allele (B*1526N) with a stop codon in exon 3 generated by a point mutation. , 1997, Tissue antigens.

[11]  E. Adams,et al.  Natural inactivation of a common HLA allele (A*2402) has occurred on at least three separate occasions. , 1997, Journal of immunology.

[12]  G. Longton,et al.  Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. , 1997, Blood.

[13]  J. McCluskey,et al.  Stable inheritance of an HLA-"blank" phenotype associated with a structural mutation in the HLA-A*0301 gene. , 1996, Tissue antigens.

[14]  S. Y. Yang,et al.  Differential effect of human and mouse beta 2-microglobulin on the induction and the antigenic profile of endogenous HLA-A and -B antigens synthesized by beta 2-microglobulin gene-null FO-1 melanoma cells. , 1993, Cancer research.

[15]  S. Y. Yang,et al.  Isoelectric focusing subtypes of HLA-A can be defined by oligonucleotide typing. , 1993, Tissue antigens.

[16]  H. Ploegh,et al.  Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. , 1986, Journal of immunology.

[17]  C. Barnstable,et al.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.

[18]  S. Yang,et al.  Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypes , 2004, Immunogenetics.

[19]  K. Tadokoro,et al.  HLA-A null allele with a stop codon, HLA-A*0215N, identified in a homozygous state in a healthy adult , 2004, Immunogenetics.

[20]  K. Welsh,et al.  Identification of the null HLA-A2 allele, A*0232N. , 2000, Tissue antigens.

[21]  C. Chapman,et al.  An HLA‐B null allele (B*0808N) caused by a nucleotide deletion in exon 3, found in the family of a bone marrow transplant recipient , 2000 .

[22]  M. Bunce,et al.  Rapid DNA typing for HLA-C using sequence-specific primers (PCR-SSP): identification of serological and non-serologically defined HLA-C alleles including several new alleles. , 1994, Tissue antigens.

[23]  S. Ferrone,et al.  Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression. , 1991, The Journal of clinical investigation.

[24]  B. Dupont,et al.  Immunobiology of HLA , 1989, Springer New York.